Cargando…
Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors
The receptor-activator of nuclear kappaB ligand (RANKL) signaling pathway plays an important role in the regulation of bone growth and mediates the formation and activation of osteoclasts. Osteoclasts are involved in significant bone resorption and destruction. Denosumab is a fully human monoclonal...
Autores principales: | Yamagishi, Tetsuro, Kawashima, Hiroyuki, Ogose, Akira, Ariizumi, Takashi, Sasaki, Taro, Hatano, Hiroshi, Hotta, Tetsuo, Endo, Naoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862691/ https://www.ncbi.nlm.nih.gov/pubmed/27163152 http://dx.doi.org/10.1371/journal.pone.0154680 |
Ejemplares similares
-
Prognostic impact of the tumor immune microenvironment in synovial sarcoma
por: Oike, Naoki, et al.
Publicado: (2018) -
Frequent expression of human leukocyte antigen class I and the status of intratumoral immune cells in alveolar soft part sarcoma
por: Ogose, Akira, et al.
Publicado: (2017) -
<Editors’ Choice>
Stanniocalcin-1 mRNA expression in soft-tissue tumors
por: Yamagishi, Tetsuro, et al.
Publicado: (2020) -
The natural history of incidental retroperitoneal schwannomas
por: Ogose, Akira, et al.
Publicado: (2019) -
Denosumab as a potential therapeutic option for leiomyosarcoma with osteoclast-like giant cells: A case report
por: Sasaki, Taro, et al.
Publicado: (2018)